ArticleFrontiers in medicine2025

Delamanid-containing regimens over 24 weeks for the treatment of multidrug-resistant/rifampicin-resistant tuberculosis: preliminary results from a single center in a multicenter, prospective, observational study.

Fuping Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.